Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minzasolmin bioavailability and food effect study in healthy volunteers
NCT06533475Phase 1Completed
- Sponsor
- UCB
- Start
- Sep 2024
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of minzasolmin (6 arms), sponsored by UCB. Primary endpoints: Area Under the Plasma Concentration-time Curve From Time 0 to t at 96 hours, Area Under the Plasma Concentration-time Curve From Zero to Infinity at 96 hours and 1 more. Started Sep 2024; status: completed.
02
Drugs
minzasolmin
Beyond the preview
Go deeper on NCT06533475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06533475.